Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 | P08588 | 8/20 | 0.49 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.49 |
| ▸ | ADRB3 | P13945 | 13/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | RORC | P51449 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6540069 | 1.00 | ADRB1 (0.49) | ADRB1ADRB2ADRB3KDM4EGAA | |
| SCHEMBL11039373 | 0.93 | ADRB1 (0.55) | ADRB1ADRB2ADRB3KDM4EGAA | |
| SCHEMBL6554433 | 0.90 | ADRB3 (0.58) | ADRB1ADRB2ADRB3 | |
| SCHEMBL6554434 | 0.90 | ADRB3 (0.58) | ADRB1ADRB2ADRB3 | |
| SCHEMBL6540513 | 0.90 | ADRB3 (0.57) | ADRB1ADRB2ADRB3 | |
| SCHEMBL6540508 | 0.90 | ADRB3 (0.48) | ADRB1ADRB2ADRB3 | |
| SCHEMBL11043555 | 0.87 | ADRB1 (0.48) | ADRB1ADRB2ADRB3KDM4EGAA | |
| Hydrochloric Acid SCHEMBL6539845 | 0.85 | ADRB3 (0.64) | ADRB1ADRB3 | |
| Hydrochloric Acid SCHEMBL6539851 | 0.85 | ADRB3 (0.64) | ADRB1ADRB3 | |
| SCHEMBL6540334 | 0.83 | ADRB1 (0.49) | ADRB1ADRB2ADRB3KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040138462-A1 | Aminoalcohol derivatives | ASTELLAS PHARMA INC. (JP) | 2004-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040138462-A1 | Aminoalcohol derivatives | BPHL, FANCD2, HRH2 | ADRB1 7/4885ADRB2 4/4885ADRB3 58/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.